Table 2 Relationship between FOXM1 protein expression and clinicopathological variables of 90 patients considered for survival analyses
Characteristic | No. | Fc | P |
|---|---|---|---|
Age | 1.41 | 0.058 | |
> 60 | 40 | ||
≤ 60 | 50 | ||
Histological type | 1.76 | 0.001 | |
Serous | 50 | ||
Non serous (14 clear-cell, 26 endometrioid) | 40 | ||
FIGO stage | 1.71 | 0.004 | |
III-IV | 57 | ||
I-II | 33 | ||
Grade | 1.33 | 0.227 | |
G3 | 73 | ||
G1-2 | 17 | ||
TR | 1.32 | 0.126 | |
> 0 | 46 | ||
0 | 44 | ||
Lymph node metastasis | 1.15 | 0.526 | |
Positive | 23 | ||
Negative | 49 | ||
Na | 18 | ||
Menopausal status | 1.06 | 0.75 | |
Pre | 63 | ||
Post | 27 | ||
Response to first line-chemotherapy | 1.22 | 0.469 | |
Non responder | 12 | ||
Responder | 77 | ||
Na | 1 | ||
Platinum sensitivity | 0.98 | 0.923 | |
Sensitive | 56 | ||
Partially sensitive-resistant | 31 | ||
Not treated | 3 | ||
Ascites | 1.28 | 0.186 | |
Yes | 53 | ||
No | 36 | ||
Na | 1 | ||
Cytology | 1.33 | 0.138 | |
Positive | 56 | ||
Negative | 27 | ||
Na | 7 | ||
CA125 | 1.04 | 0.683 | |
1SD increase | |||